CAMP4 Therapeutics Corporation (NASDAQ:CAMP) Short Interest Update

CAMP4 Therapeutics Corporation (NASDAQ:CAMP) was the target of a significant increase in short interest in June. As of June 30th, there was short interest totaling 1,311,363 shares, an increase of 229.0% from the June 15th total of 398,648 shares. Currently, 3.2% of the shares of the stock are sold short. Based on an average daily volume of 559,861 shares, the short-interest ratio is presently 2.3 days.

Wall Street Analysts Forecast Growth

CAMP has been the subject of a number of recent research reports. Weiss Ratings downgraded shares of CAMP4 Therapeutics from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, May 21st. Rodman & Renshaw began coverage on shares of CAMP4 Therapeutics in a research note on Tuesday, April 14th. They issued a “buy” rating and a $7.00 price target for the company. JPMorgan Chase & Co. upgraded CAMP4 Therapeutics from a “neutral” rating to an “overweight” rating and increased their price objective for the stock from $5.00 to $9.00 in a research report on Tuesday, June 16th. Chardan Capital set a $6.50 target price on CAMP4 Therapeutics and gave the company a “buy” rating in a research report on Wednesday, June 10th. Finally, Leerink Partners raised their price objective on CAMP4 Therapeutics from $8.00 to $9.00 and gave the stock an “outperform” rating in a research report on Thursday, April 2nd. Seven equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, CAMP4 Therapeutics has a consensus rating of “Moderate Buy” and an average target price of $8.36.

CAMP4 Therapeutics Trading Up 0.9%

CAMP traded up $0.04 during mid-day trading on Tuesday, hitting $4.54. 130,759 shares of the stock were exchanged, compared to its average volume of 175,880. The company has a market cap of $235.76 million, a PE ratio of -1.92 and a beta of 0.10. The firm’s fifty day moving average is $4.27 and its two-hundred day moving average is $4.60. CAMP4 Therapeutics has a 1-year low of $1.32 and a 1-year high of $7.75.

CAMP4 Therapeutics (NASDAQ:CAMP) last posted its quarterly earnings data on Thursday, May 7th. The Wireless communications provider reported ($0.32) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.11). The business had revenue of $1.29 million during the quarter. CAMP4 Therapeutics had a negative net margin of 2,193.72% and a negative return on equity of 194.74%. As a group, research analysts anticipate that CAMP4 Therapeutics will post -0.84 earnings per share for the current year.

Institutional Investors Weigh In On CAMP4 Therapeutics

Several large investors have recently bought and sold shares of the stock. Vivo Capital LLC acquired a new position in shares of CAMP4 Therapeutics during the third quarter worth about $11,765,000. Balyasny Asset Management L.P. purchased a new stake in shares of CAMP4 Therapeutics in the 4th quarter valued at approximately $14,938,000. Janus Henderson Group PLC raised its holdings in shares of CAMP4 Therapeutics by 35.9% in the 4th quarter. Janus Henderson Group PLC now owns 6,307,636 shares of the Wireless communications provider’s stock valued at $38,807,000 after purchasing an additional 1,666,666 shares in the last quarter. SummitTX Capital L.P. purchased a new stake in shares of CAMP4 Therapeutics during the 1st quarter worth $1,497,000. Finally, EcoR1 Capital LLC purchased a new position in CAMP4 Therapeutics in the fourth quarter valued at $1,992,000.

About CAMP4 Therapeutics

CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company operates in two segments, Software & Subscription Services and Telematics Products. It provides CalAmp Telematics Cloud platform, such as cloud-based application enablement and telematics service platforms that facilitate integration of its own applications, as well as those of third parties, through open application programming interfaces; and software as a service application, as well as provides tracking and monitoring services within fleet management, supply chain integrity, and international vehicle location.